Linden Thomas Advisory Services, LLC Novo Cure LTD Transaction History

Linden Thomas Advisory Services, LLC

  • $647 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024
BUY
$12.42 - $17.29 $1,105 - $1,538
89 Added 0.68%
13,126 $205 Million
Q4 2023

Feb 01, 2024
BUY
$11.13 - $15.78 $979 - $1,388
88 Added 0.68%
13,037 $195 Million
Q3 2023

Oct 20, 2023
BUY
$16.15 - $42.35 $209,126 - $548,390
12,949 New
12,949 $209 Million

Others Institutions Holding NVCR

# of Institutions
272
Shares Held
77.1M
Call Options Held
751K
Put Options Held
293K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.54B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Linden Thomas Advisory Services, LLC Portfolio

Follow Linden Thomas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linden Thomas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Linden Thomas Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email